GlassScriptPhysician profile
Evan Kelly
NPI 1124478458
$12,719.22
in general payments reported to CMS, 2019-2025
13 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $4,291 · 2023: $2,861 · 2024: $4,473 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,618 · Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,617.64 |
| Food and Beverage | $1,565.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $2,436.50 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Boston Scientific Corporation | $2,131.79 | 2022-2025 | Apollo Esg System, Apollo Esg Nxt System, Wallflex Duodenal |
| Tela Bio, INC. | $1,693.52 | 2024 | Ovitex 2s |
| Globus Medical, INC. | $1,538.67 | 2024-2025 | Alif, Alif Instruments (Universal), Maxcess |
| Northern X-Ray Company | $1,449.96 | 2023 | Interventional Angiography System |
| W. L. Gore & Associates, INC. | $1,167.65 | 2022 | |
| Medtronic, INC. | $887.33 | 2021-2023 | Beacon |
| Stryker Corporation | $780.91 | 2022 | |
| Philips North America LLC | $474.85 | 2022 | |
| Lumendi LLC | $78.50 | 2025 | |
| Abbvie INC. | $47.42 | 2022-2023 | |
| Mauna Kea Technologies, INC. | $17.57 | 2024 | |
| Teleflex LLC | $14.55 | 2025 | Titan Sgs Bailout Chuck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.